Impact of time-varying exposure on estimated effects in observational studies using routinely collected data: protocol for a cross-sectional study
暂无分享,去创建一个
Weiqi Wang | Xin Sun | J. Guo | Ling Li | Jing Tan | Kevin Z Lu | Guowei Li | Mei Liu | Jiayue Xu | Wen Wang
[1] J. Meerpohl,et al. Evaluating agreement between bodies of evidence from randomised controlled trials and cohort studies in nutrition research: meta-epidemiological study , 2021, BMJ.
[2] R. Burge,et al. Comparison of Two-Year Treatment Adherence, Persistence, Discontinuation, Re-initiation, and Switching Between Psoriasis Patients Treated with Ixekizumab or Secukinumab in Real-World Settings. , 2021, Journal of the American Academy of Dermatology.
[3] M. Pencina,et al. Competing Risks, Treatment Switching, and Informative Censoring. , 2021, JAMA cardiology.
[4] P. Austin,et al. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors. , 2021, JAMA cardiology.
[5] H. Leslie,et al. Quality of clinical management of children diagnosed with malaria: A cross-sectional assessment in 9 sub-Saharan African countries between 2007–2018 , 2020, PLoS medicine.
[6] R. Burge,et al. Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab , 2020, Patient preference and adherence.
[7] Xu Zhou,et al. The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist. , 2019, Journal of clinical epidemiology.
[8] P. Clare,et al. Causal models adjusting for time-varying confounding-a systematic review of the literature. , 2018, International journal of epidemiology.
[9] Olaf Klungel,et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) , 2018, British Medical Journal.
[10] Jacqueline Corrigan-Curay,et al. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness. , 2018, JAMA.
[11] G. D. Dal Pan,et al. Assessing Drug Safety in Children - The Role of Real-World Data. , 2018, The New England journal of medicine.
[12] P. Stang,et al. Methods for time‐varying exposure related problems in pharmacoepidemiology: An overview , 2017, Pharmacoepidemiology and drug safety.
[13] Lisa M. LaVange,et al. Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" Data. , 2017, JAMA.
[14] S. Langan,et al. The reporting of studies using routinely collected health data was often insufficient , 2016, Journal of clinical epidemiology.
[15] H. Sørensen,et al. Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study , 2016, BMJ Open.
[16] M. Nørgaard,et al. How can the research potential of the clinical quality databases be maximized? The Danish experience , 2016, Journal of internal medicine.
[17] David Moher,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.
[18] D Kalra,et al. Electronic health records: new opportunities for clinical research , 2013, Journal of internal medicine.
[19] G. Guyatt,et al. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis. , 2013, Journal of clinical epidemiology.
[20] Scott R. Smith,et al. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide , 2013 .
[21] X. Basagaña,et al. Differences Between Marginal Structural Models and Conventional Models in Their Exposure Effect Estimates: A Systematic Review , 2011, Epidemiology.
[22] David Moher,et al. An evidence-based practice guideline for the peer review of electronic search strategies. , 2009, Journal of clinical epidemiology.
[23] Samy Suissa,et al. Immortal time bias in pharmaco-epidemiology. , 2008, American journal of epidemiology.
[24] L. Napolitano,et al. Surgical Clinics of North America , 2019, Surgical Clinics of North America.
[25] Charles Kaye Friedberg,et al. Progress in Cardiovascular Diseases , 1959 .